Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis

Immune-checkpoint inhibitors (ICIs) have widened the therapeutic scenario of different cancer types. Phase I/II trials have been designed to evaluate the role of ICIs both as single agents and in combination in neuroendocrine neoplasms (NENs), but as yet no randomized controlled phase III trials hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongiovanni, Alberto, Maiorano, Brigida Anna, Azzali, Irene, Liverani, Chiara, Bocchini, Martine, Fausti, Valentina, Di Menna, Giandomenico, Grassi, Ilaria, Sansovini, Maddalena, Riva, Nada, Ibrahim, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155858/
https://www.ncbi.nlm.nih.gov/pubmed/34067837
http://dx.doi.org/10.3390/ph14050476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155858/
https://www.ncbi.nlm.nih.gov/pubmed/34067837
http://dx.doi.org/10.3390/ph14050476

Ejemplares similares